X-ray-facilitated redox cycling of nanozyme possessing peroxidase-mimicking activity for reactive oxygen species-enhanced cancer therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34274779.
- Also identified by DOI 10.1016/j.biomaterials.2021.121023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nanomaterials with shifting or mixed redox states is one of the most common studied nanozyme with peroxidase-like activity for chemodynamic therapy (CDT), which can decompose hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) of tumor microenvironment into highly toxic reactive oxygen species (ROS) by a nano-catalytic way. However, most of them exhibit an insufficient catalytic efficiency due to their dependence on catalytic condition. Herein, a potential methodology is proposed to enhance their enzymatic activity by accelerating the redox cycling of these nanomaterials with shifting or mixed redox states in the presence of X-ray. In this study, the nanocomposite consisting of SnS<sub>2</sub> nanoplates and Fe<sub>3</sub>O<sub>4</sub> quantum dots with shifting or mixed redox states (Fe<sup>2+</sup>/Fe<sup>3+</sup>) is used to explore the strategy. Under external X-ray irradiation, SnS<sub>2</sub> cofactor as electron donor can be triggered to transfer electrons to Fe<sub>3</sub>O<sub>4</sub>, which promotes the regeneration of Fe<sup>2+</sup> sites on the surface of the Fe<sub>3</sub>O<sub>4</sub>. Consequently, the regenerated Fe<sup>2+</sup> sites react with the overexpressed H<sub>2</sub>O<sub>2</sub> to persistently generate ROS for enhanced tumor therapy. The designed nanocomposite displays the synergistic effects of radiotherapy and CDT. The strategy provides a new avenue for the development of artificial nanozymes with shifting or mixed redox states in precise cancer treatments based on X-ray-enhanced enzymatic efficacy.
Medical subject headings
- Nanocomposites
- Neoplasms